D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
GTHX holding history
G1 Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GTHX overviewAll 13F holders of GTHXFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −767,066−100.0% | Sold out | Holders |
| Q2 2024 | 767,066 | $1.75M | <0.1% | −18,193−2.3% | Reduced | Holders |
| Q1 2024 | 785,259 | $3.39M | <0.1% | +289,808+58.5% | Added | Holders |
| Q4 2023 | 495,451 | $1.51M | <0.1% | −9,631−1.9% | Reduced | Holders |
| Q3 2023 | 505,082 | $727.3K | <0.1% | −111,421−18.1% | Reduced | Holders |
| Q2 2023 | 616,503 | $1.54M | <0.1% | +186,864+43.5% | Added | Holders |
| Q1 2023 | 429,639 | $1.15M | <0.1% | −15,068−3.4% | Reduced | Holders |
| Q4 2022 | 444,707 | $2.41M | <0.1% | +349,733+368.2% | Added | Holders |
| Q3 2022 | 94,974 | $1.19M | <0.1% | −42,005−30.7% | Reduced | Holders |
| Q2 2022 | 136,979 | $677.0K | <0.1% | +136,979 | New | Holders |